Heart transplants: Do more or do none, study suggests

Heart surgeons at Johns Hopkins have evidence to support further tightening rather than easing of standards used to designate hospitals that are best at performing heart transplants.

In a study to be presented Jan. 29 at the 44th annual meeting of the Society of Thoracic Surgeons in Fort Lauderdale, Fla., the Hopkins team recommends that the benchmark for designation as a high-volume hospital rise from 10 heart transplants per year to 14. High-volume centers consistently show higher survival and fewer complication rates.

However, the standard, which is officially set by the U.S. Centers for Medicare and Medicaid Services and which qualifies medical centers for federal reimbursement, was recently lowered from 12 per year to 10.

“The bar for patient safety, quality of care and survival needs to be set pretty high,” says senior study investigator and cardiac surgeon John Conte, M.D. “Our national health care system has to rethink which hospitals should do heart transplants, and in consultation with their physicians, patients need to evaluate these surgical volumes to see for themselves which hospitals have teams operating at their peak skill level.”

Conte and his team reviewed the patient records of 14,401 men and women who received a heart transplant in the United Stats between 1999 and 2006.

The study is believed to be the largest and most thorough review of survival rates after heart transplantation in hospitals, based on volume.

“Our results clearly demonstrate that current standards have been arbitrarily set too low,” says Conte, who is director of heart and lung transplantation at The Johns Hopkins Hospital.

“There is a certain threshold, a minimum number of surgeries needed to maintain the expertise of the entire transplant team,” he says, noting that a dozen or more highly specialized professionals are involved in each transplant case, including cardiac surgeons, cardiologists, anesthesiologists, transplant coordinators, intensive care nurses, immunologists, pathologists, pulmonologists, and technicians.

In the new study, researchers found that death rates one month and one year after transplant increased steadily at hospitals that performed fewer than 14 heart transplants per year, which was the case for a majority of the 143 U.S. medical centers licensed to perform them. Roughly a dozen institutions perform more than 20 cases annually - including The Johns Hopkins Hospital and the University of Maryland Medical Center - and fewer than 10 hospitals do more than 30 procedures, with no more than five sites performing more than 40.

Study results showed that the overall average death rate one year after surgery was 12.6 percent. However, patients had a 16 percent greater chance of dying in a hospital that performed fewer than five heart transplants per year and had the best chances of surviving, with a 30-day mortality rate of less than 1 percent, at a hospital that performed over 40 procedures per year. Patients at hospitals with volumes of less than 10 had an 80 percent greater chance of dying within a month.

Using a graph and statistical analysis, researchers showed that death rates flattened for the majority of patients in hospitals with heart transplant volumes at 14 or more per year.

Conte, an associate professor of surgery at The Johns Hopkins University School of Medicine and its Heart Institute, says heart-failure patients on transplant wait lists should consult with their cardiologists about hospital and surgeon volumes when making decisions about transplants.

Hopkins cardiologist and study co-investigator Stuart Russell, M.D., who has personally cared for more than 360 transplant patients in the past decade, says patients should also look for consistently high volumes over several years as well as overall survival rates for transplant programs.

One-year survival rates at The Johns Hopkins Hospital, he notes, consistently average above 90 percent.

Despite the team’s findings, Russell says it will take a clear shift in public health policy to move American medicine toward further concentration of volumes for complex procedures such as heart transplantation.

In the United Kingdom, he points out, centers designated to performed heart transplants are severely restricted, and volumes soar past 50 for each center.

“In the United States, too many low-volume hospitals have a program that they won’t let go of, no matter how poor the results,” says Russell, an associate professor at Hopkins.

More than 2,000 people undergo heart transplants each year in the United States. Nearly 3,000 remain on wait lists, and up to 20 percent of those on the list to receive a heart will die while waiting. Costs for a heart transplant often run as high as $260,000.

Source: Johns Hopkins Medical Institutions

Related stories:

Transfusion expert urges wider use of filtered blood
Filtering white cells from donor blood before a transfusion is much safer for patients and long overdue as a national standard for all surgical procedures, according to University of Rochester researchers who present their analysis in the April journal, Transfusion.
The beat goes on: Artificial heart technology holds promise for alternatives
Patients on the waiting list for a heart transplant soon may have more options thanks to a new device being developed by the Texas Heart Institute in collaboration with two University of Houston professors.
Study finds barriers to angioplasty for life-threatening heart attacks
Women, the elderly, and patients admitted to the emergency department on weekends are all less likely to receive same-day coronary angioplasty for a life-threatening heart attack in Florida, University of South Florida researchers found. Their study was published this month (Oct. 1) in the American Journal of Cardiology.
Can stem cells heal damaged hearts? No easy answers, but some signs of hope
Recent studies indicate that infusing hearts with stem cells taken from bone marrow could improve cardiac function after myocardial infarction (tissue damage that results from a heart attack). But in a recent systematic review, Cochrane Researchers concluded that more clinical trials are needed to assess the effectiveness of stem cell therapies for heart patients, as well as studies to establish how these treatments work.
China vows overhaul of 'chaotic' milk industry
(AP) -- China's Cabinet vowed a complete overhaul of the scandal-ridden dairy industry Monday, pledging to inspect every link from the farm to the dinner table to try to restore public trust in Chinese-made food products.
Where you live matters when you're seriously ill
America does a mediocre job caring for its sickest people. The nation, says a new report, gets a C.
Disease diagnosis in just 15 minutes
Testing for diseases such as cancer and multiple sclerosis could soon be as simple as using a pregnancy testing kit.
Hospital deaths of 40 newborns shocks Turkey
(AP) -- Outside the Zekai Tahir Burak maternity hospital stands a bronze statue of a mother nursing a baby with an inscription from the Prophet Mohammed: "Paradise lies at the feet of the mother."

News discussion:

Medicine & Health news